Holen Sie sich die Stockscreener-App
1.23
1.60%
-0.02
Schlusskurs vom Vortag:
$1.25
Offen:
$1.28
24-Stunden-Volumen:
26,048
Relative Volume:
0.05
Marktkapitalisierung:
$3.23M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-15.52M
KGV:
-0.0662
EPS:
-18.58
Netto-Cashflow:
$-16.61M
1W Leistung:
-7.52%
1M Leistung:
-16.33%
6M Leistung:
-89.29%
1J Leistung:
-91.29%
1-Tages-Spanne:
$1.21
$1.29
1-Wochen-Bereich:
$1.19
$1.355
52-Wochen-Spanne:
$1.19
$15.20
Revelation Biosciences Inc Stock (REVB) Company Profile
Firmenname
Revelation Biosciences Inc
Sektor
Branche
Telefon
650-800-3717
Adresse
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
1.23 | 3.28M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.05 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.80 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
724.82 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.19 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
290.39 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Revelation Biosciences Inc Aktie (REVB) Neueste Nachrichten
Dividend Watch: Can Revelation Biosciences Inc beat the S P 500Quarterly Market Summary & Low Drawdown Investment Ideas - baoquankhu1.vn
REVB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Revelation Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Sheboygan Press
EPS Watch: Does Revelation Biosciences Inc Equity Warrant stock benefit from AI growthJuly 2025 Reactions & Community Driven Trade Alerts - baoquankhu1.vn
Weekly Recap: Is enGene Holdings Inc forming bullish engulfing patternsPrice Action & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Activity Recap: What is Revelation Biosciences Inc Equity Warrants valuation compared to sectorEarnings Trend Report & Real-Time Market Trend Scan - baoquankhu1.vn
REVB: 2026 Begins with Financial Picture in Good Shape - Research Tree
REVB Should I Buy - Intellectia AI
Revelation Biosciences, Inc. Announces Financial Results For the Three and Twelve Months Ended December 31, 2025 - newswire.com
Revelation Biosciences Q4 net loss widens - TradingView
Revelation Biosciences (REVB) cuts 2025 loss, extends cash runway into early 2027 - Stock Titan
Kidney drug Gemini advances at Revelation, cash runway into 2027 - Stock Titan
Decliners Report: What is the Moat Score of Revelation Biosciences Inc2025 Support & Resistance & High Accuracy Investment Signals - baoquankhu1.vn
EBITDA per share of Revelation Biosciences, Inc. – NASDAQ:REVBW - TradingView
Revelation Biosciences (REVB) to Release Quarterly Earnings on Thursday - Defense World
Income Plays: Whats the beta of Revelation Biosciences Inc stockTrade Risk Summary & Verified Stock Trade Ideas - baoquankhu1.vn
Analyst Upgrade: What is the Moat Score of Revelation Biosciences IncPortfolio Return Summary & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Revelation Biosciences Inc. to Present at The International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026) - Beaver County Times
Can Revelation Biosciences Inc. stock beat market expectations this quarterWeekly Stock Summary & Weekly Watchlist for Hot Stocks - mfd.ru
Quarterly Risk: Can Revelation Biosciences Inc lead its sector in growthWatch List & Real-Time Buy Signal Notifications - baoquankhu1.vn
Aug Levels: What is the Moat Score of Revelation Biosciences IncRate Hike & Momentum Based Trading Ideas - baoquankhu1.vn
Energy Moves: Is Revelation Biosciences Inc Equity Warrant backed by strong institutional buying2025 Market Sentiment & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Portfolio Shifts: How does Revelation Biosciences Inc compare to its peersWeekly Market Outlook & Entry and Exit Point Strategies - baoquankhu1.vn
Bearish Setup: Whats the profit margin of Revelation Biosciences Inc Equity Warrant2025 Key Lessons & Real-Time Volume Spike Alerts - baoquankhu1.vn
How does Revelation Biosciences Inc. compare to its peersJuly 2025 Review & Fast Gain Stock Trading Tips - mfd.ru
Is Revelation Biosciences Inc. stock positioned for digital transformationTrade Risk Assessment & AI Forecasted Entry/Exit Points - mfd.ru
Revelation Biosciences Inc. Announces Exercise of Warrants for $11 Million in Gross Proceeds - Columbia Daily Tribune
What makes Revelation Biosciences Inc. stock attractive todayJuly 2025 Big Picture & High Return Trade Guides - mfd.ru
Why retail investors pile into Revelation Biosciences Inc. stockInsider Selling & Weekly Setup with ROI Potential - mfd.ru
Revelation Biosciences Announces Initiation of GMP Manufacturing of GEMINI and Placebo to Support Later Stage Clinical Development - Lubbock Avalanche-Journal
What’s the RSI of Revelation Biosciences Inc. Equity Warrant stockMarket Risk Analysis & Technical Buy Zone Confirmation - mfd.ru
Can Revelation Biosciences Inc. deliver alphaJuly 2025 Reactions & Reliable Momentum Entry Alerts - mfd.ru
Will Revelation Biosciences Inc. stock gain from lower inflation2025 Key Highlights & Daily Market Momentum Tracking - mfd.ru
Warrant holders register 4.27M Revelation (Nasdaq: REVB) shares - Stock Titan
Breakout Zone: What are the risks of holding Revelation Biosciences IncJuly 2025 Fed Impact & Fast Entry Momentum Alerts - baoquankhu1.vn
Revelation Biosciences (REVB) Price Target Increased by 300.00% to 86.70 - Nasdaq
Fundamentals Check: What is Graf Global Corp Debt Equity Composite Unitss valuation compared to sectorJuly 2025 Breakouts & AI Driven Price Forecasts - baoquankhu1.vn
Buyback Watch: Is ETHE trading at a discountJuly 2025 Market Mood & Expert Verified Stock Movement Alerts - baoquankhu1.vn
Finanzdaten der Revelation Biosciences Inc-Aktie (REVB)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.97%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):